Departments of Neurosurgery.
Biostatistics and Bioinformatics.
Clin Spine Surg. 2022 Nov 1;35(9):E725-E730. doi: 10.1097/BSD.0000000000001363. Epub 2022 Jul 14.
Retrospective cohort study.
We aimed to characterize the treatment patterns and the associated costs in patients with cerebrospinal fluid (CSF) leak after spine procedures in the United States.
CSF leak is a common complication after spinal procedures. However, there is a little data regarding the national patterns of treatment choice and the associated health care resource utilization.
We utilized the IBM MarketScan Research databases to retrospectively analyze adult US patients diagnosed with CSF leak within 30 days of spine procedures between 2001 and 2018. Treatment prevalence, treatment failure, and health care resource utilization data within 30 days of the CSF leak were collected. A subanalysis was performed on patients who received epidural blood patches (EBP) to better understand health care utilization attributable to this treatment modality.
Twenty one thousand four hundred fourteen patients were identified. The most common causes of CSF leak were diagnostic spinal tap (59.2%) and laminectomy/discectomy (18.7%). With regard to treatment prevalence, 40.4% of the patients (n=8651) had conservative medical management, 46.6% (n=9987) received epidural blood patch repair, 9.6% required surgical repair (n=2066), and 3.3% (n=710) had lumbar drain/puncture. Nine hundred sixty-seven (9.7%), 150 (21.1%), and 280 (13.5%) patients failed initial EBP, lumbar drain, and surgery, respectively, and the overall failure rate was 10.9% (n=1397). The median 30-day total cost across all groups was $5,101. Patients who received lumbar drain ($22,341) and surgical repair ($30,199) had higher 30-day median total costs than EBP ($8,140) or conservative management ($17,012). The median 30-day total cost for patients whose EBP failed ($8,179) was substantially greater than those with a successful EBP repair ($3,439).
National treatment patterns and costs for CSF leaks were described. When used in the correct patient cohort, EBP has the lower failure rates and costs than comparable alternatives. EBP may be considered more often in situations where conservative management or lumbar drains are currently being used.
回顾性队列研究。
我们旨在描述美国脊柱手术后发生脑脊液(CSF)漏患者的治疗模式和相关费用。
CSF 漏是脊柱手术后常见的并发症。然而,关于治疗选择的国家模式和相关医疗资源利用的数据很少。
我们利用 IBM MarketScan 研究数据库,回顾性分析了 2001 年至 2018 年期间,30 天内脊柱手术后诊断为 CSF 漏的美国成年患者。收集了 CSF 漏后 30 天内的治疗流行率、治疗失败和医疗资源利用数据。对接受硬膜外血贴(EBP)的患者进行了亚分析,以更好地了解这种治疗方式的医疗利用情况。
共确定了 21414 例患者。CSF 漏最常见的原因是诊断性椎管穿刺(59.2%)和椎板切除术/椎间盘切除术(18.7%)。在治疗流行率方面,40.4%的患者(n=8651)接受了保守的药物治疗,46.6%(n=9987)接受了硬膜外血贴修复,9.6%需要手术修复(n=2066),3.3%(n=710)接受了腰椎引流/穿刺。967(9.7%)、150(21.1%)和 280(13.5%)例患者的初始 EBP、腰椎引流和手术分别失败,总失败率为 10.9%(n=1397)。所有组的 30 天总费用中位数为 5101 美元。接受腰椎引流(22341 美元)和手术修复(30199 美元)的患者的 30 天总费用中位数高于 EBP(8140 美元)或保守治疗(17012 美元)。EBP 治疗失败(8179 美元)患者的 30 天总费用中位数明显高于 EBP 治疗成功(3439 美元)患者。
描述了 CSF 漏的国家治疗模式和费用。当在正确的患者群体中使用时,EBP 的失败率和成本低于可比的替代方法。在当前使用保守治疗或腰椎引流的情况下,可能会更频繁地考虑 EBP。